# PsyLabs Ltd.

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/psylabs-ltd
Canonical HTML page: https://getbiobrief.com/entity/psylabs-ltd

## Recent coverage (1 stories)

### Psyence BioMed Secures Supply Chain via Strategic PsyLabs Equity Investment
2026-02-21 00:40:46 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Psyence Biomedical Ltd. (Nasdaq: PBM) has confirmed a strategic equity investment in PsyLabs following the exercise of a pre-existing put option agreement. The transaction reinforces the vertical integration between the clinical-stage developer and its primary source of pharmaceutical-grade, nature-derived psychedelic compounds.
Full story: https://getbiobrief.com/story/psyence-biomed-psylabs-equity-investment-put-option

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.